Imagine
developing a drug designed to inhibit a protein that helps cancer cells proliferate and survive only to find that the drug does not perform very well in the clinic.
Not exact matches
Drugs that were effective at warding off infections decades ago are now less potent because the bacteria they were
designed to kill have
developed defence mechanisms.
Elion and Hitchings
developed a method known as «rational
drug design» that helped revolutionize
drug making.
Rõivas, the former Prime Minister, says Estonia is working on
developing «precision medicine» that would tap into the genome data of its 1.3 million citizens in order to better diagnose illnesses, treat people, and
design personalized
drugs.
What Boger wants is to create a better way to
develop drugs: through a process called structure - based
design in which scientists build up a new
drug, atom by atom, after determining the type of molecule that might interrupt the disease process.
Many of the candidate
drugs developed in recent years were
designed to clear these protein aggregates.
The research team currently is working to identify new biomarkers that will allow them to
develop a better understanding of how
drug resistance
develops, and how to best
design effective combinations of medications that may improve patient responses.
Dr. Melnick
developed the first BCL6 inhibitors nine years ago, and has continued to improve upon the
design of these
drugs so they could be used to treat cancer patients.
«Understanding how
drug resistance
develops can help in the
design of new agents or strategies to overcome resistance,» says principal investigator Sameek Roychowdhury, MD, PhD, assistant professor of medicine and of pharmacology in the Division of Medical Oncology at the OSUCCC — James.
«The challenge has been how to direct certain therapies
designed to manipulate genes of interest in specific cells without
developing a specific
drug carrier for each specific cell type.
«We're doing a lot of work to improve clinical trial
design and to improve the way
drugs are discovered and
developed,» Perlmutter says.
Researchers at the San Diego Supercomputer Center at the University of California, San Diego, have
developed software that greatly expands the types of multi-scale QM / MM (mixed quantum and molecular mechanical) simulations of complex chemical systems that scientists can use to
design new
drugs, better chemicals, or improved enzymes for biofuels production.
These so - called artemisinin combination therapies (ACTs)-- there are six combinations — are
designed to stave off resistance, in much the same way that combinations curb HIV's ability to
develop resistance to any single
drug.
Drugs designed to selectively block activated BRAF have led to significant improvement in clinical response and overall survival in melanoma patients, but resistance to these drugs often develops — leading to recurr
Drugs designed to selectively block activated BRAF have led to significant improvement in clinical response and overall survival in melanoma patients, but resistance to these
drugs often develops — leading to recurr
drugs often
develops — leading to recurrence.
The
drug candidates it has
developed are
designed for single pathogens, not multiple threats.
Scientists have
developed a three - in - one blood test that could transform treatment of advanced prostate cancer through use of precision
drugs designed to target mutations in the BRCA genes.
When Theravance, the company in South San Francisco, California, that
developed the
drug,
designed the large phase III clinical trials needed for approval, the FDA simply required a demonstration that the
drug eliminated symptoms of infection as reliably as the approved antibiotic vancomycin.
We refer to these as «alerts»: they can be used by
drug design experts to try to avoid certain interactions and / or structures in order to
develop safer
drugs,» says Aloy.
«Now, because we know the resistance mechanism, we can
design elements to minimize the emergence of resistance as these promising new
drug candidates are
developed,» said Ben Shen, a TSRI professor who led the study, which was published February 20, 2014 online ahead of print by the Cell Press journal Chemistry & Biology.
Professor Michael Lisanti, who
designed the study, explained: «We now know that a proportion of cancer cells escape chemotherapy and
develop drug resistance; we established this new strategy to find out how they do it.
This knowledge may be used to
develop new ways for opening the blood - brain - barrier to increase the efficacy of the brain cancer
drugs and for the
design of treatment regimes that strengthens the integrity of the blood - brain barrier.»
Anderson and Valerie Grum - Tokars, a junior structural biologist on the team,
developed a three - dimensional structure of human p38 MAPK, enabling the chemists to
design and synthesize novel
drug - like small molecules that would disable it.
Prof. Joost Schymkowitz and Prof. Frederic Rousseau of VIB - KU Leuven in collaboration with Prof. Johan Van Eldere of University Hospitals Leuven have gone one step further: they have
developed a new way of
designing antibiotic
drugs that can give rise to many new antibacterial molecules.
Until now, agents that inhibit Pin1 have been
developed mainly through rational
drug design.
Inspired by the earlier work, Deborah Fuller from the University of Washington in Seattle, USA, who is interested in
developing influenza
drugs and vaccines, teamed up with David Baker, also at the University of Washington, who is an expert in computational protein
design.
Janssen GPH will also prioritise work with the International Partnership for Microbicides
developing the investigational
drug dapivirine for use as a monthly vaginal microbicidal ring
designed to prevent sexual transmission of HIV and continue its pact with
Drugs for Neglected Diseases initiative for the preclinical research of a reformulated form of flubendazole for lymphatic filariasis (elephantiasis) and onchocerciasis (river blindness), Janssen GPH is also
developing a new, chewable formulation of Vermox (mebendazole) that will facilitate treatment of intestinal worms in younger children.
--
Drug design: we
develop new virtual screening and chemoinformatics methods.
WASHINGTON, DC — May 16, 2010 — At a time when the cost of
developing a new
drug is skyrocketing and research money is tight, it is important to be creative in
designing new therapies for rare diseases and bringing them to market, according to speakers at the eighth Annual Meeting of the American Society for -LSB-...]
Candix AB, in cooperation with Nanexa AB,
develops Nanocontainers for
drug delivery using a proprietary nanotechnology platform that enables flexible
design to optimize performance properties.
Our
Drug Design Studio is a proprietary digital tool
developed by our in - house software engineering team.
I got a new laboratory of research in bioinformatics and computational chemistry, in which we
develop mostly studies in
drug design and in silico evaluation of environmental pollutants, and I also proposed a new master program in Bioinformatics.
To address this growing problem, NIAID is funding and conducting research on many aspects of antimicrobial (
drug) resistance, including basic research on how microbes
develop resistance, development of new and faster diagnostics, and clinical trials
designed to find new vaccines and treatments effective against
drug - resistant microbes.
Swedish researchers are
developing a new
drug designed to curb alcoholism.
Panne's findings led to a side project on structure - based
drug design with industry partners to
develop novel
drugs.
A bioengineer in the College of Engineering and Computer Science at Florida Atlantic University has received a $ 141,743 grant from the National Cancer Institute of the National Institutes of Health to
develop a novel biodegradable polymer stent that will be
designed to prevent complications while at the same time serving as a
drug delivery system for esophageal cancer therapy.
Drug from Mediterranean Weed Kills Tumor Cells Scientists at the Johns Hopkins Kimmel Cancer Center, working with Danish researchers, have developed a novel anticancer drug designed to travel — undetected by normal cells — through the bloodstream until activated by specific cancer prote
Drug from Mediterranean Weed Kills Tumor Cells Scientists at the Johns Hopkins Kimmel Cancer Center, working with Danish researchers, have
developed a novel anticancer
drug designed to travel — undetected by normal cells — through the bloodstream until activated by specific cancer prote
drug designed to travel — undetected by normal cells — through the bloodstream until activated by specific cancer proteins.
Other companies, including the Swiss
drug giants Novartis and Roche, along with Boston's Paratek Pharmaceuticals, are
developing ingestible small - molecule
drugs designed to increase the inclusion of SMN2 «s exon 7.
Rational
drug design develops fewer compounds compared to high - throughput screening.
Further the Meiler laboratory
develops a structure - based
drug design module for ROSETTA and docking protocols particularly suited for docking small molecules into comparative models.
CancerNetwork speaks with Patricia S. Steeg, PhD, who has recently written a perspective in the journal Nature calling for a shift in both the types of
drugs that are
developed for breast cancer and in the way clinical trials are
designed and executed.
We have
designed and
developed a data integration and visualization platform that provides evidence about the association of known and potential
drug targets with diseases.
The space was also
designed with the public in mind, featuring interactive tour stops throughout the lab space that use technology to underscore IDRI's work in
developing vaccines,
drugs and diagnostics, as well as large built - in windows to showcase IDRI's specialized facilities, including manufacturing.
That's why I have been working with my editorial team to
develop a series of comprehensive, yet easy - to - read health books and free special reports
designed to give you the tools you need to take control of your health the natural way, without dangerous pharmaceutical
drugs.
Children as young as 18 months are now receiving antipsychotic
drugs, despite the fact that the diseases they're
designed to treat rarely
develop before adolescence.
For example, the difference between investigating the chemical properties of a new compound versus
designing a marketable
drug, or in education, between funding research in neuroscience versus
developing that research into instructional resources).
All Acting Vs. Writing Advertising Apps For Writers Art Author Collectives Banning Books Blogging Blog Tours Book Cover
Design Book Marketing Booksellers Branding Character Development Character - Driven Fiction Christian Erotica Clichés In Writing Co-Authoring Construction Coping With Anxiety Coping With Rejection Letters Copyright Copyright Infringement Copywriting Creating A Business Plan Dealing With Fear Defining Success Depression
Developing Setting
Drug & / or Alcohol Abuse Editing Vs. Writing Editors Education Entrepreneurial Skills Ethical Issues In Fiction Evoking Emotion Expat Writers Fame Fantasy Finding Inspiration Finding Your Voice Follow Your Dreams For Aspiring Writers For Indie Authors Gender Issues Genre Getting Published Ghostwriting Grief Handling Critique Historical Fiction Horror Stories In Publishing Interdisciplinary Art Karma Lit Killing Off Characters Learning From Mistakes LGBT LGBT Literature Literary Adaptations Literary Journals Lyrics Mailing Lists Marketing Memoir Metaphysical Lit Multicultural Fiction Music Music Vs. Writing Nonfiction Nonfiction To Fiction Nurturing Creativity Packaging Advice Perfectionism Photography Playwriting Plotting Poetry Political Art Pornography Protagonist Development Public Speaking Publishing Religion Research Romance Novels Self - doubt Selfpublishing Setting Goals Social Effects Of Fiction Social Media Social Networking Spiritual Lit Staying Motivated Stereotypes Success Taking Care Of Yourself Taking Risks Target Audience Thrillers Time Management Time Travel Traditional Publishing Trilogy Trust Your Instincts Truth In Fiction Twitter For Writers Typesetting Websites Work / Life Balance Writer Quirks Writer's Block Writers» Conference Writer's Life Writing Advice Writing A Series Writing As Therapy Writing Book Reviews Writing Craft Writing Dialects Writing Erotica Writing For A Living Writing For Children Writing (General) Writing Groups Writing In A Foreign Language Writing Playlists Writing Sequels Writing Vs. Medicine Writing Workshops Writing Yourself Into Your Characters Youth Arts Youth Education
The Pharmacy Services segment operates retail and mail order pharmacies, and specialty pharmacies for individuals that require complex
drug therapies;
designs and administers pharmacy benefit plans for its clients (including Medicare Part D services); and
develops and operates Pharmacy Services information systems.
1) Equitable
drug design: The BRF is committed to
developing new therapies, especially
designed to treat cancer in pets but also to benefit people as well.
Drug companies have
developed a large number of NSAIDs
designed especially for dogs.
Because of advances in
drug design and precision medicine, researchers have been able to target certain molecules within a cell at the root of a particular disease and to
develop specific therapies...